MedTrace Logo

Atrial Sensing Capability for Better Detection of Atrial Fibrillation

NCT03932604 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 640

Last updated 2021-10-04

No results posted yet for this study

Summary

This prospective multi-center randomized controlled study aims to compare atrial fibrillation detection and inappropriate therapy according to activation of atrial sensing capability in patients with implantable cardioverter defibrillator.

Conditions

Interventions

DEVICE

Atrial sensing On mode

Single lead VDD-ICD programmed as atrial sensing On mode.

Sponsors & Collaborators

  • Biotronik SE & Co. KG

    collaborator INDUSTRY

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Seung-Jung Park, PhD · Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2021-12-31
Completion
2023-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03932604 on ClinicalTrials.gov